DK0825859T3 - Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed - Google Patents

Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed

Info

Publication number
DK0825859T3
DK0825859T3 DK96919731T DK96919731T DK0825859T3 DK 0825859 T3 DK0825859 T3 DK 0825859T3 DK 96919731 T DK96919731 T DK 96919731T DK 96919731 T DK96919731 T DK 96919731T DK 0825859 T3 DK0825859 T3 DK 0825859T3
Authority
DK
Denmark
Prior art keywords
forskolin
treatment
drug
manufacture
extracts containing
Prior art date
Application number
DK96919731T
Other languages
Danish (da)
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK0825859T3 publication Critical patent/DK0825859T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK96919731T 1995-05-19 1996-05-09 Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed DK0825859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI951023A IT1275436B (it) 1995-05-19 1995-05-19 Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza
PCT/EP1996/001952 WO1996036332A1 (fr) 1995-05-19 1996-05-09 Utilisation de forskoline ou d'extraits contenant cette substance dans la fabrication d'un medicament destine au traitement de l'alcoolisme

Publications (1)

Publication Number Publication Date
DK0825859T3 true DK0825859T3 (da) 2002-07-29

Family

ID=11371634

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919731T DK0825859T3 (da) 1995-05-19 1996-05-09 Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed

Country Status (18)

Country Link
US (1) US5902823A (fr)
EP (1) EP0825859B1 (fr)
JP (1) JP3001641B2 (fr)
KR (1) KR100423486B1 (fr)
CN (1) CN1099286C (fr)
AT (1) ATE215368T1 (fr)
AU (1) AU697449B2 (fr)
CA (1) CA2221592C (fr)
DE (1) DE69620394T2 (fr)
DK (1) DK0825859T3 (fr)
ES (1) ES2175099T3 (fr)
HK (1) HK1005651A1 (fr)
HU (1) HU223474B1 (fr)
IT (1) IT1275436B (fr)
NO (1) NO316054B1 (fr)
PT (1) PT825859E (fr)
RU (1) RU2183455C2 (fr)
WO (1) WO1996036332A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2243005T3 (es) 1997-07-30 2005-11-16 Indena S.P.A. Extracto de soja, proceso para su preparacion y composicion farmaceutica.
EP1645272A3 (fr) * 1998-05-12 2008-11-05 The Endowment For Research In Human Biology, Inc. Dérivés de daidzin pour le traitement de l'alcoolisme
US20060122261A1 (en) * 2003-11-20 2006-06-08 Muhammed Majeed [method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
WO2008042795A2 (fr) * 2006-09-29 2008-04-10 The Board Of Trustees Of The University Of Illinois Activateurs de l'histone acétyltransférase et inhibiteurs d'histone déacétylase dans le traitement de l'alcoolisme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120975A (en) * 1976-08-26 1978-10-17 Fisons Limited Method of psychiatric conditions
US4782082A (en) * 1982-12-27 1988-11-01 Schering Corporation Method for treating allergic reactions with Forskolin
IL89530A0 (en) * 1989-03-08 1989-09-10 Jeffrey J Feigenbaum Compositions containing forskolin
US5366990A (en) * 1991-11-14 1994-11-22 Reid Larry D Method for treating alcohol abuse and alcoholism

Also Published As

Publication number Publication date
US5902823A (en) 1999-05-11
DE69620394T2 (de) 2002-10-02
EP0825859A1 (fr) 1998-03-04
RU2183455C2 (ru) 2002-06-20
DE69620394D1 (de) 2002-05-08
AU5816396A (en) 1996-11-29
KR100423486B1 (ko) 2004-06-05
NO316054B1 (no) 2003-12-08
IT1275436B (it) 1997-08-07
HUP9801236A2 (hu) 2000-06-28
KR19990014876A (ko) 1999-02-25
AU697449B2 (en) 1998-10-08
NO975155D0 (no) 1997-11-10
EP0825859B1 (fr) 2002-04-03
PT825859E (pt) 2002-08-30
CA2221592A1 (fr) 1996-11-21
WO1996036332A1 (fr) 1996-11-21
JPH11500738A (ja) 1999-01-19
ITMI951023A1 (it) 1996-11-19
NO975155L (no) 1997-11-10
JP3001641B2 (ja) 2000-01-24
HK1005651A1 (en) 1999-01-22
CN1099286C (zh) 2003-01-22
CA2221592C (fr) 2002-07-09
ATE215368T1 (de) 2002-04-15
CN1184422A (zh) 1998-06-10
ITMI951023A0 (it) 1995-05-19
HU223474B1 (hu) 2004-07-28
HUP9801236A3 (en) 2001-09-28
ES2175099T3 (es) 2002-11-16

Similar Documents

Publication Publication Date Title
SE9604793D0 (sv) New polymorphs
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69512930D1 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
NO971766D0 (no) Anvendelsen av dioksomorfoliner for bekjempning av endoparasitter, nye dioksomorfoliner samt deres fremstilling
SE9402422D0 (sv) New beads for controlled release and a pharmaceutical preparation containing the same
ATE209918T1 (de) Transdermales estradiol/progestogen-pflaster und dessen herstellung
SE9601421D0 (sv) New composition
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
ES2162110T3 (es) Derivados de la quinolina antimalaria.
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DE69831409D1 (de) Chalcon-derivate mit antiproliferativer aktivität
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
DE69411726D1 (de) Zusammensetzungen zur freigabe einer aromatischen substanz in die nase
IS5366A (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
DK0825859T3 (da) Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
ATE215525T1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
KR970701687A (ko) 레조르시놀로부터의 4, 6-디니트로레조르시놀의 일단계 제조방법 (One-step preparation of 4,6-dinitroresorcinol from resorcinol)
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
ES2190951T3 (es) Microemulsion, conteniendo sales de alcanolamonio de los alquilsulfatos y/o alquilpolialquilenglicoletersulfatos.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives